您的位置: 首页 > 农业专利 > 详情页

Protein nanostructure based drug delivery system for the delivery of therapeutic agents to the anterior segment of the eye
专利权人:
Council of Scientific and Industrial Research
发明人:
申请号:
GB201807475
公开号:
GB201807475D0
申请日:
2016.11.16
申请国别(地区):
GB
年份:
2018
代理人:
摘要:
A multifunctional system in which a nanostructure (size range of about 10-1000 nm) degrades on exposure to an infection and its associated inflammatory milieu. The degraded nanostructures release the encapsulated drug during the process of degradation, where the kinetics of drug release is determined by the severity of the infection and inflammation. This degradation is triggered by proteases secreted by the pathogen, host polymorphonuclear leucocytes and other host cells. The nanostructures are conjugated to anti-TLR (Toll-like receptor) ligands for targeting the corneal epithelium and blocking the inflammatory pathway.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充